Multimodal imaging merges two or more imaging modalities in one probe, combining the advantages of the individual techniques.^[@ref1]^ For instance, significant research has been conducted to develop probes for dual magnetic resonance imaging (MRI), which features no tissue penetrating limit, and real-time optical imaging.^[@ref2],[@ref3]^ Nanoparticles are a promising class of multimodal imaging agents as the blending of their specific imaging components typically does not affect the pharmacokinetic profile of the nanoparticle, frequently a disadvantage for small molecular probes.^[@ref4]^ Furthermore, nanoparticles can be decorated with a variety of targeting moieties, giving rise to useful multivalent modes of interaction and functionality.^[@ref5]^ Nanoparticles self-assembled from small molecular building blocks provide facile points of entries into tuning of materials properties and have shown potential for bioimaging.^[@ref6]−[@ref9]^ We have previously reported on a class of π-conjugated small molecule-based nanoparticles (SMNP) with high fluorescent quantum yields.^[@ref10]−[@ref12]^ The small molecular building blocks consist of short π-conjugated oligomers that can be functionalized with side-chains of different polarity and with bioactive functionalities at the extremities of inert ethylene glycol side chains. Tuning of the side-chain properties allows for control over molecular polarity, generation of amphiphilic analogues, and particle assembly characteristics.^[@ref11],[@ref12]^ The modular nature of these building blocks and their self-assembly characteristics also allows the blending of differently functionalized amphiphilic small-molecules (**amps**, [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}) to produce spherical, amorphous SMNPs with different, useful properties for in vitro applications.^[@ref12],[@ref13]^ Despite this potential, though, the use of such SMNPs as optical, multimodal imaging agents has not been investigated *in vivo*. In this regard, the introduction of a radiolabel would be beneficial as it would act as a sensitive, orthogonal readout on the biodistribution of the SMNPs in tissues and organs. Here, we report the efficient conjugation of a radiolabel to a SMNP making use of the bio-orthogonal inverse-electron-demand Diels--Alder (IEDDA) reaction between a tetrazine (Tz) and *trans*-cyclooctene (TCO)^[@ref14]−[@ref16]^ ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}) and subsequently assess the potential of the resulting conjugated SMNPs as *in vivo* dual-mode imaging agents.

![(A) Chemical Structures of **amp**-inert^[@ref11]^ and **amp**-TCO, π-Conjugated Small Molecules, Which Self Assemble into SMNPs. (B) Two-Step Radiolabeling Strategy Starts with Chelation of the Radioisotope to the Tetrazine-DOTA Derivative Followed by (C) Conjugation to the SMNP Co-Self-Assembled from **amp**-inert and **amp**-TCO](bc-2019-00038s_0004){#sch1}

Our radiolabeling strategy centered on the efficient conjugation of a Tz-DOTA derivative, prechelated to the radioisotope, to preassembled SMNPs. This maximized flexibility, while minimizing the number of radioactive handling steps. Radiolabeling of the Tz-DOTA was performed as described in the literature.^[@ref17]^ Briefly, a small amount of Tz-DOTA was dissolved in 0.2 M ammonium acetate buffer (pH 5.5) followed by the addition of indium-111. After 5 min incubation at 60 °C the solution was treated with DTPA to yield \>99.7% ^111^In-labeled Tz-DOTA (based on iTLC). A small molecule building block featuring a reactive *trans*-cyclooctene unit (**amp**-TCO, [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}) was synthesized and coassembled with **amp**-inert (25% **amp**-TCO) into SMNPs in a facile manner. Next, the Tz-DOTA derivative was reacted with the TCO-bearing SMNPs in buffer over 30 min. Reversed-phase (RP)-TLC studies on the ^111^In-labeled Tz-DOTA and SMNPs ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}A) revealed the extent of the ^111^In-labeling. Whereas the unreacted ^111^In-labeled Tz-DOTA eluted with an *R*~f~ = 0.3, with and without **amp**-inert as a control, most of the indium-111 activity was observed to colocalize with the SMNPs at the baseline (*R*~f~ \< 0.1) after conjugation. The low activity observed at *R*~f~ \> 0.1, corresponding to residual unreacted Tz-DOTA or free indium-111, could be removed by size exclusion chromatography. Analysis of the reaction mixtures using a phosphorimager ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}B) or under 365 nm UV-light ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}C) also indicated almost full conversion of the Tz-DOTA based on the colocalization of the indium-111 radio activity and the SMNP fluorescence signal. Besides the successful Tz-DOTA conjugation using the **amp**-TCO building block, these results indicate that all radioisotope labeling is specifically incorporated through a covalent reaction between the ^111^In-labeled Tz-DOTA and the **amp**-TCO, and not due to nonspecific, noncovalent incorporation of the Tz-DOTA or indium-111 label into the SMNPs.

![(A) Reversed phase (RP)-TLC using 50% acetonitrile/water of ^111^In-labeled Tz-DOTA (magenta), ^111^In-labeled Tz-DOTA with inert-SMNPs (blue), ^111^In-labeled Tz-DOTA combined with SMNPs featuring with 25% **amp**-TCO before (red) and after purification by size exclusion chromatography (black). (B) RP-TLC of purified ^111^In-labeled SMNP imaged with phosphorimager and (C) fluorescence.](bc-2019-00038s_0001){#fig1}

Two other radiolabeling strategies were also investigated for the conjugation of the indium-111 to SMNPs: one based on SMNPs self-assembled with a DOTA connected building block (**amp**-DOTA), the other on a two-step labeling protocol using a bicyclononyne-DOTA conjugate (BCN-DOTA) (see [SI](http://pubs.acs.org/doi/suppl/10.1021/acs.bioconjchem.9b00038/suppl_file/bc9b00038_si_001.pdf) for synthesis and characterization details). SMNPs composed of **amp**-DOTA could be radiolabeled with indium-111 with an efficiency of 45%. The excess of radioactive indium-111 could in part be removed via extensive purification by size exclusion column chromatography, leading to 88% of the radioactivity resulting from the SMNPs (SI [Figure S5](http://pubs.acs.org/doi/suppl/10.1021/acs.bioconjchem.9b00038/suppl_file/bc9b00038_si_001.pdf)). While promising, this labeling efficiency was nonetheless too low for *in vivo* applications. The BCN-DOTA derivative by contrast did not show any reaction with the SMNPs assembled from **amp**-azide monomers, presumably due to the azide group's lack of solvent accessibility within the SMNPs. The limitations of these two strategies combined with the results obtained for the Tz-TCO conjugation strategy, testify to the suitability of the latter for use with SMNPs.

The particle and materials characteristics of the SMNP before and after the Tz-DOTA conjugation via the IEDDA reaction were further evaluated using cold-control studies. SMNPs consisting of 25% of **amp**-TCO and 75% **amp**-inert, measured an average diameter of 90 nm by DLS. Incubating the same SMNPs in serum did not influence their optical properties ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). The quantum yield of the SMNPs was determined to be 0.46 and the absorption cross section was 6.7 × 10^--12^ cm^2^. Coupling of Tz-DOTA to the SMNPs did not influence the size or optical properties of the particles, nor did subsequent purification by size exclusion chromatography (SI [Figure S9](http://pubs.acs.org/doi/suppl/10.1021/acs.bioconjchem.9b00038/suppl_file/bc9b00038_si_001.pdf)).

![(A) Excitation (left) and emission spectra (right) of 25% TCO-SMNPs in water and after 17 h incubation in serum at 37 °C. (B) Hydrodynamic diameter of SMNPs containing 25% **amp**-TCO in water.](bc-2019-00038s_0002){#fig2}

The promising optical and structural characteristics of the SMNPs and their facile radiolabeling, prompted the study of their functioning as dual-imaging agents in vivo. The ^111^In-labeled SMNPs were administrated intravenously to mice, to profile their intrinsic *in vivo* biodistribution and clearance. The mice did not show any changes in behavior or activity over a period of 3 days, indicating that the SMNPs were well tolerated by the mice at peak blood concentrations of 30 μM. Blood samples taken via the *vena saphena* were weighed and analyzed by γ-counter ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}A insert). Heparin was present during blood sampling to increase the efficiency of sample handling during the subsequent fluorescence analysis. After injection of the SMNPs, the observed percentage dose per gram in blood was measured to be 17.3 ± 1.3 ID/g after 2 min, which dropped to 4.4 ± 0.9% ID/g after 5 min, followed by an average value of 0.9 ± 0.2% ID/g after 10 min, indicating that most SMNPs were efficiently cleared from the bloodstream. The biodistribution of the SMNPs was determined periodically (4, 24, and 70 h post administration of SMNPs; [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}A) by harvesting the organs at the indicated times after anesthetized cervical dislocation and then weighing and γ-counting the percentage injected dose per gram tissue (% ID/g). At the 4 h time point, the SMNPs had been predominantly taken up in the liver with 80.4 ± 3.7% ID/g, with significant uptake measured in the spleen as well (34.8 ± 1.8% ID/g). These observations are possibly explained by mononuclear phagocytic system (MPS) elimination by macrophages localized in the liver (Kupffer cells) and the spleen (red pulp) as is commonly observed.^[@ref18]^ No uptake in lung tissue was observed, which is expected for nonaggregated particles smaller than 2000 nm in diameter.^[@ref19]^

![(A) Biodistribution of SMNPs in mice 4, 24, and 70 h after i.v. administration (error bar represents SEM, *n* = 3, \* *p* \< 0.05). (inset) blood clearance of SMNPs in mice (error bar represents SEM, *n* = 4). (B) Fluorescence spectrum of SMNPs in blood (black line), corrected for non-SMNP containing blood, and fluorescence spectrum of SMNPs in PBS (red line). Error area represents SD, *n* = 3.](bc-2019-00038s_0003){#fig3}

The SMNPs levels in liver and spleen decreased after 24 and 70 h, which is indicative of effective excretion from the body, possibly after SMNP disassembly, via solvation into hydrophobic compartments.^[@ref19]^ In this respect, it is worth mentioning that Tz-DOTA itself has been reported elsewhere to clear rapidly via the kidneys.^[@ref17],[@ref20]^ By comparison, no renal clearance was observed for the SMNPs, strengthening the conclusion that all DOTA present is covalently attached via the tetrazine-TCO conjugation chemistry and not nonspecifically incorporated in the SMNP.^[@ref21]^

Besides the radiotracer imaging, the fluorescence of the SMNPs was evaluated as a second mode of imaging. The liver tissue's autofluorescent properties prevented detection of the SMNPs by microscopy imaging in this organ. Emission spectra could, however, be recorded for the SMNPs in blood samples collected after SMNP injection. Subtraction of blood background fluorescence clearly revealed the typical fluorescence signature of the SMNPs ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}B). While scattering effects of the blood^[@ref22]^ probably account for the fluctuations observed for the SMNP spectrum, the spectral profile shape fits well with the one measured in PBS, indicating that these SMNPs are indeed detectable in complex blood tissue.

In summary, we have shown that intrinsically fluorescent self-assembled nanoparticles (SMNP) prepared through coassembly of π-conjugated building blocks could be efficiently radiolabeled by the IEDDA reaction between a ^111^In-labeled tetrazine-DOTA derivative and a TCO-SMNP. Dual radiotracer and fluorescence imaging studies revealed a rapid clearance of the SMNPs from the blood, and efficient uptake in the liver and spleen with subsequent clearance. These first studies serve to demonstrate the potential of self-assembled, small molecule based, nanoparticles as dual mode imaging agents. However, further improvements are needed. For example, fluorescence-based detection in liver tissue should be possible by tuning the absorption and emission characteristics through chemical modification of the constituent monomers.^[@ref23]^ More extensive PEGylation of the SMNPs would potentially confer stealth-like properties for applications requiring longer circulation times.^[@ref19]^ In this respect, the selectivity and efficiency of the IEDDA reaction should facilitate access to such modified SMNPs.
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